| Abstrakt: |
A recent report from NOVA Southeastern University discusses the role of neuroinflammation and neurodegeneration markers in brain disorders, emphasizing the importance of biomarkers in understanding disease pathogenesis, severity, and progression. The study highlights the potential of evaluating neuroinflammatory markers in blood, cerebrospinal fluid, or brain tissues to assess disease severity and therapeutic responsiveness. The research suggests that integrating these markers into clinical practice could lead to early diagnosis, disease monitoring, and improved therapeutic outcomes for conditions such as Alzheimer's disease, Parkinson's disease, and dementia. [Extracted from the article] |
